KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 57 filers reported holding KALEIDO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,026,000 | -31.0% | 1,833,832 | 0.0% | 0.62% | +10.4% |
Q4 2021 | $4,383,000 | -56.2% | 1,833,832 | 0.0% | 0.56% | -40.5% |
Q3 2021 | $10,013,000 | -26.6% | 1,833,832 | 0.0% | 0.94% | -27.8% |
Q2 2021 | $13,644,000 | -8.1% | 1,833,832 | 0.0% | 1.30% | -34.5% |
Q1 2021 | $14,854,000 | -11.0% | 1,833,832 | 0.0% | 1.99% | -69.5% |
Q4 2020 | $16,688,000 | -28.8% | 1,833,832 | -4.5% | 6.52% | -24.8% |
Q3 2020 | $23,435,000 | +72.0% | 1,920,027 | +4.7% | 8.67% | +47.7% |
Q2 2020 | $13,625,000 | +89.8% | 1,833,832 | +57.1% | 5.87% | +69.5% |
Q1 2020 | $7,178,000 | +22.5% | 1,167,166 | 0.0% | 3.46% | +43.6% |
Q4 2019 | $5,859,000 | -33.3% | 1,167,166 | 0.0% | 2.41% | -34.0% |
Q3 2019 | $8,789,000 | -67.5% | 1,167,166 | -50.0% | 3.66% | -27.8% |
Q2 2019 | $27,078,000 | +60.0% | 2,334,332 | +100.0% | 5.06% | -15.4% |
Q1 2019 | $16,924,000 | – | 1,167,166 | – | 5.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 19,575,710 | $32,300,000 | 0.76% |
HARBOURVEST PARTNERS LLC | 1,833,832 | $3,026,000 | 0.62% |
Palo Alto Investors LP | 309,692 | $511,000 | 0.04% |
Artal Group S.A. | 500,500 | $826,000 | 0.04% |
FEDERATED HERMES, INC. | 607,687 | $1,003,000 | 0.00% |
IHT Wealth Management, LLC | 18,890 | $31,000 | 0.00% |
Close Asset Management Ltd | 7,900 | $19,000 | 0.00% |
FMR LLC | 6,389,660 | $10,543,000 | 0.00% |
Baillie Gifford | 733,525 | $1,211,000 | 0.00% |
Texas Yale Capital Corp. | 10,000 | $17,000 | 0.00% |